Worry has flared up because the S&P 500 has risen nearly 90% since its surge began in late 2022. These 11 Stocks Are Probably in a Bubble. It’s Time to Get Out. The stocks are all tied to Wall ...
Pfizer has won a $10 billion deal to acquire obesity drug developer Metsera, securing foothold in lucrative weight-loss treatment market. Rep. Jeff Van Drew, R-N.J., says safety is the number one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback